Trial Profile
RANDOMIZED CLINICAL EVALUATION OF EFFECTIVENESS COMPARISON BETWEEN DRUGS OPHTHALMOLOGICAL TOBRACORT (TOBRAMYCIN + DEXAMETHASONE - LAB. UNIAO QUIMICA)AND TOBRADEX (TOBRAMYCIN + DEXAMETHASONE - LAB. ALCON) IN REDUCING THE SIGNS AND SYMPTOMS OF ACUTE BACTERIAL CONJUNCTIVITIS.
Status:
Not yet recruiting
Phase of Trial:
Phase III
Latest Information Update: 20 Jan 2020
Price :
$35
*
At a glance
- Drugs Tobramycin/dexamethasone (Primary)
- Indications Bacterial infections; Infectious conjunctivitis
- Focus Adverse reactions; Therapeutic Use
- 01 Nov 2010 New trial record